Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Anaplastic Large Cell Lymphoma
Medical College of WisconsinP1CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disease
Medical College of WisconsinP1CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Primary Cutaneous Anaplastic Large Cell Lymphoma
Medical College of WisconsinP1CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Diffuse Large B-Cell Lymphoma
Medical College of WisconsinP1CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Hodgkins Lymphoma
Medical College of WisconsinP1CC (43)
Anti-Cd33 Car T-Cells
Hematopoietic And Lymphoid Cell Neoplasm
iCell Gene TherapeuticsP1CC (43)
Anti-Cd5 Car Nk Cells
T Lymphoblastic Leukemia/Lymphoma
Chongqing Precision Biotech Co., LtdP1CC (43)
Anti-Cea Car-T Cells
Liver Cancer
Changhai HospitalP1CC (43)
Anti-Cll-1 Car Nk Cells
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Atypical Teratoid Rhabdoid Tumor
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Diffuse Intrinsic Pontine Glioma
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Head And Neck Squamous Cell Carcinoma
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Nasopharyngeal Type Undifferentiated Carcinoma
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Medulloblastoma
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Childhood Malignant Neoplasm
Sun Yat-sen UniversityP1CC (43)
Anti-EGFR Antibody-drug Conjugate MRG003
Wilms Tumor
Sun Yat-sen UniversityP1CC (43)
Anti-Flt3 Car-T Cells
Acute Myeloid Leukemia
Hemogenyx Pharmaceuticals LLCP1CC (43)
Antigen-Specific Igt Cells
Brain Glioblastoma
Shenzhen Geno-Immune Medical InstituteP1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)P1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Follicular Lymphoma
National Cancer Institute (NCI)P1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (43)
Anti-Icos Monoclonal Antibody Medi-570
Mycosis Fungoides
National Cancer Institute (NCI)P1CC (43)
Anti-IL13Ralpha2 CAR T-cells
Astrocytoma, IDH-Mutant, Grade 4
City of Hope Medical CenterP1CC (43)
Anti-IL13Ralpha2 CAR T-cells
IDH-Wildtype Glioblastoma
City of Hope Medical CenterP1CC (43)
Showing 926 to 950 of 9,928 assets
PreviousPage 38 of 398Next